Collison Kate S, Inglis Angela, Shibin Sherin, Andres Bernard, Ubungen Rosario, Thiam Jennifer, Mata Princess, Al-Mohanna Futwan A
Department of Cell Biology, King Faisal Specialist Hospital & Research Centre, PO Box 3354, Riyadh 11211, Saudi Arabia.
Department of Cell Biology, King Faisal Specialist Hospital & Research Centre, PO Box 3354, Riyadh 11211, Saudi Arabia.
Physiol Behav. 2016 Dec 1;167:209-221. doi: 10.1016/j.physbeh.2016.09.011. Epub 2016 Sep 15.
We have previously showed that lifetime exposure to aspartame, commencing in utero via the mother's diet, may impair insulin tolerance and cause behavioral deficits in adulthood via mechanisms which are incompletely understood. The role of the CNS in regulating glucose homeostasis has been highlighted by recent delineation of the gut-brain axis, in which N-methyl-d-aspartic acid receptors (NMDARs) are important in maintaining glucose homeostasis, in addition to regulating certain aspects of behavior. Since the gut-brain axis can be modulated by fetal programming, we hypothesized that early-life NMDAR antagonism may affect aspartame-induced glucose deregulation in adulthood, and may alter the aspartame behavioral phenotype. Accordingly, C57Bl/6J mice were chronically exposed to aspartame commencing in utero, in the presence and absence of maternal administration of the competitive NMDAR antagonist CGP 39551, from conception until weaning. Drug/diet interactions in adulthood glucocentric and behavioral parameters were assessed. Aspartame exposure elevated blood glucose and impaired insulin-induced glucose disposal during an insulin tolerance test, which could be normalized by NMDAR antagonism. The same effects were not observed in control diet mice, suggesting an early-life drug/diet interaction. Behavioral analysis of adult offspring indicated that NMDAR antagonism of control diet mice caused hyperlocomotion and impaired spatial navigation. Conversely hypolocomotion, reduced exploratory activity and increased anxiety-related behavior were apparent in aspartame diet mice with early-life NMDAR antagonism.
significant drug/diet interactions in glucocentric and behavioral parameters were identified in aspartame-exposed mice with early-life NMDAR antagonism. This suggests a possible involvement of early NMDAR interactions in aspartame-impaired glucose homeostasis and behavioral deficits.
我们之前已经表明,从子宫内通过母体饮食开始终生接触阿斯巴甜,可能会损害胰岛素耐受性,并通过尚未完全了解的机制导致成年期行为缺陷。最近对肠脑轴的描述突出了中枢神经系统在调节葡萄糖稳态中的作用,其中N-甲基-D-天冬氨酸受体(NMDARs)除了调节行为的某些方面外,在维持葡萄糖稳态中也很重要。由于肠脑轴可通过胎儿编程进行调节,我们假设早期NMDAR拮抗作用可能会影响成年期阿斯巴甜诱导的葡萄糖失调,并可能改变阿斯巴甜的行为表型。因此,从受孕到断奶,在有和没有母体给予竞争性NMDAR拮抗剂CGP 39551的情况下,C57Bl/6J小鼠从子宫内开始长期接触阿斯巴甜。评估成年期以葡萄糖为中心的参数和行为参数中的药物/饮食相互作用。在胰岛素耐受性试验中,阿斯巴甜暴露会升高血糖并损害胰岛素诱导的葡萄糖处理,而NMDAR拮抗作用可使其正常化。在对照饮食小鼠中未观察到相同的效果,这表明存在早期药物/饮食相互作用。对成年后代的行为分析表明,对照饮食小鼠的NMDAR拮抗作用会导致运动亢进和空间导航受损。相反,在具有早期NMDAR拮抗作用的阿斯巴甜饮食小鼠中,运动减少、探索活动减少和焦虑相关行为增加很明显。
在有早期NMDAR拮抗作用的阿斯巴甜暴露小鼠中,在以葡萄糖为中心的参数和行为参数中发现了显著的药物/饮食相互作用。这表明早期NMDAR相互作用可能参与了阿斯巴甜损害的葡萄糖稳态和行为缺陷。